Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know

In the latest close session, Cardinal Health (CAH) was up +2.42% at $211.31. The stock fell short of the S&P 500, which registered a gain of 2.91% for the day. Meanwhile, the Dow gained 2.49%, and the Nasdaq, a tech-heavy index, added 3.83%. The prescription drug distributor's shares have seen a decrease of 10.25% over the last month, not keeping up with the Medical sector's loss of 9.63% and the S&P 500's loss of 7.64%.The investment community will be paying close attention to the earnings performance of Cardinal Health in its upcoming release. The company is slated to reveal its earnings on April 30, 2026. The company is predicted to post an EPS of $2.8, indicating a 19.15% growth compared to the equivalent quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $62.42 billion, indicating a 13.74% growth compared to the corresponding quarter of the prior year. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $10.31 per share and revenue of $259.27 billion. These totals would mark changes of +25.12% and +16.48%, respectively, from last year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Cardinal Health. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Cardinal Health is holding a Zacks Rank of #2 (Buy) right now. Digging into valuation, Cardinal Health currently has a Forward P/E ratio of 20. This represents a premium compared to its industry average Forward P/E of 15.01. Investors should also note that CAH has a PEG ratio of 1.33 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CAH's industry had an average PEG ratio of 1.77 as of yesterday's close. The Medical - Dental Supplies industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 52, positioning it in the top 22% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks